Generics Market Overview in Canada

  • August 2013
  • -
  • MarketLine
  • -
  • 34 pages

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information.


What's In This Report


* Contains an executive summary and data on value, volume and/or key market segments


* Provides textual analysis of ’s recent performance and future prospects


* Incorporates in-depth environment and competition analysis and scorecards (substitution threats, new entrants, bargaining power …)


* Includes a five-year projection of


* The main industry players are profiled with supporting key financial metrics


* Supported by the key macroeconomic and demographic data affecting the industry


Key Market Facts


* Detailed information is included on industry size, measured by value and/or volume


* Five forces scorecards provide an accessible yet in depth view of the industry ’s key competitors

This Report Will Support Your Decision Making Process


* Anticipate Industry trends and developments


* Feed your decision making process


* Make your presentation and marketing materials more valuable


* Save time

Market Definition

For the purposes of this Profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generic drugs and all branded generic drugs are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' industry, are not included. The industry value is evaluated at ex-factory prices. Industry volume is quantified here as the percentage of the total ethical pharmaceutical industry volume in a country or region which is accounted for by generic drugs. It is therefore a generic drugs penetration rate measure, not an absolute measure of industry volume. All currency conversions were calculated at constant average annual 2009 exchange rates.

For the purposes of this market research report, the Americas consists of North America and South America.

North America consists of Canada, Mexico, and the United States.

South America comprises Argentina, Brazil, Chile, Colombia, and Venezuela.

Table Of Contents

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET VOLUME 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 15
Supplier power 16
New entrants 17
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Apotex, Inc. 21
Mylan Laboratories Inc. 23
Teva Pharmaceutical Market 26
MARKET FORECASTS 30
Market value projection 30
Market volume projection 31
MACROECONOMIC INDICATORS 32
APPENDIX 34
Methodology 34
Industry associations 35
Related Datamonitor research 35
Disclaimer 36
ABOUT DATAMONITOR 37
Premium Reports 37
Summary Reports 37
Datamonitor consulting 37


Index of Tables
Data table 1: Canada generics drugs market sales : USD billion, 2005-09 10
Data table 2: Canada generics drugs industry volume: volume penetration, 2005-09 11
Data table 3: Canada generics drugs industry sector ation II: % share, by value, 2009 12
Data table 4: Apotex, Inc.: key facts 21
Data table 5: Mylan Laboratories Inc.: key facts 23
Data table 6: Mylan Laboratories Inc.: key financials ($) 24
Data table 7: Mylan Laboratories Inc.: key financial ratios 24
Data table 8: Teva Pharmaceutical Market : key facts 26
Data table 9: Teva Pharmaceutical Market : key financials ($) 28
Data table 10: Teva Pharmaceutical Market : key financial ratios 28
Data table 11: Canada generics drugs market sales projection : USD billion, 2009-14 30
Data table 12: Canada generics drugs industry volume projection : volume penetration, 2009-14 31
Data table 13: Canada size of population (million), 2005-09 32
Data table 14: Canada gdp (constant 2000 prices, USD billion), 2005-09 32
Data table 15: Canada gdp (current prices, USD billion), 2005-09 32
Data table 16: Canada inflation, 2005-09 33
Data table 17: Canada consumer price index (absolute), 2005-09 33
Data table 18: Canada exchange rate, 2005-09 33


Index of Figures
Chart 1: Canada generics drugs market sales : USD billion, 2005-09 10
Chart 2: Canada generics drugs industry volume: volume penetration, 2005-09 11
Chart 3: Canada generics drugs industry sector ation II: % share, by value, 2009 12
Chart 4: Forces driving competition in the generics drugs industry in Canada, 2009 13
Chart 5: Drivers of buyer power in the generics drugs industry in Canada, 2009 15
Chart 6: Drivers of supplier power in the generics drugs industry in Canada, 2009 16
Chart 7: Factors influencing the likelihood of new entrants in the generics drugs industry in Canada, 2009 17
Chart 8: Factors influencing the threat of substitutes in the generics drugs industry in Canada, 2009 19
Chart 9: Drivers of degree of rivalry in the generics drugs industry in Canada, 2009 20
Chart 10: Mylan Laboratories Inc.: revenues and profitability 25
Chart 11: Mylan Laboratories Inc.: assets and liabilities 25
Chart 12: Teva Pharmaceutical Market : revenues and profitability 29
Chart 13: Teva Pharmaceutical Market : assets and liabilities 29
Chart 14: Canada generics drugs market sales projection : USD billion, 2009-14 30
Chart 15: Canada generics drugs industry volume projection : volume penetration, 2009-14 31

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Analyzing the Global Generics Industry 2014

Analyzing the Global Generics Industry 2014

  • $ 1 750
  • Industry report
  • May 2014
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2014

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

  • $ 495
  • Industry report
  • April 2014
  • by MarketLine

Introduction In October 2013, Teva announced that it would be cutting approximately 10% of the workforce in order to cut costs. Later that month, it announced the departure of its CEO of just 18 months, ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Global Hyaluronic Market 2012-2016

October 2013 $ 2 500

Global Generics, Marketline

August 2013 $ 350

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.